Merck & Co (MRK)

$131.19 0.31 (0.24%)

19:00 EDT MRK Stock Quote Delayed 30 Minutes

Storm Shelter: 7 Safe Haven Stocks to Batten Down the Hatches

By Josh Enomoto, InvestorPlace Contributor May 17, 2024

With the market potentially entering a period of consolidation, investors may want to consider safe haven stocks to buy. No, it’s not the most exciting…

The 3 Most Undervalued Healthcare Stocks to Buy in May 2024

7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025

3 Pharma Stocks With the Potential to Make You an Overnight Millionaire

Volume:

Previous Close -

Market Cap 332.09B

PE Ratio 145.77

EPS 0.9

Volume (Avg. Vol.) 8.30M

Day's Range $129.81 - $131.32

52-Week Range $99.14 - $133.10

Dividend & Yield $2.92 (2.23%)

MRK Stock Predictions, Articles, and Merck & Co News

From InvestorPlace
From the Web

MRK Stock Earnings: Merck & Co Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings Apr 25, 2024

MRK stock results show that Merck & Co beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Investor Alert: Prepare for the Market Crash With These 3 Stocks

By Faisal Humayun, InvestorPlace Contributor Apr 23, 2024

These are the low-beta and attractively valued stocks to buy for a market crash as they represent companies with strong fundamentals.

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

By Faisal Humayun, InvestorPlace Contributor Apr 23, 2024

These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth.

Coming FDA Approvals Could Send These 3 Drug Stocks Soaring

By Chandler Capital, InvestorPlace Contributor Apr 17, 2024

When it comes to drug stocks, FDA approval can bring years or even decades of steady, high-margin revenue.

3 Dow Stocks to Buy Now: Q2 Edition

By Josh Enomoto, InvestorPlace Contributor Apr 16, 2024

Let’s be real – the narrative for Dow stocks to buy now tends to be one of relative safety. What are the chances that the…

7 A-Rated Aggressive Biotech Stocks to Bet On in 2024

By Louis Navellier and the InvestorPlace Research Staff Apr 12, 2024

We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades.

Golden Years Gainers: 3 Stocks to Fund Your Dream Retirement

By Noah Bolton, InvestorPlace Contributor Apr 8, 2024

A popular and rewarding goal in investing is building a strong portfolio for retirement. These retirement stocks should help.

The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024

By Michael Que, InvestorPlace Contributor Apr 7, 2024

Our economy is on the up and up, and investing is a must,. Let's review the most undervalued S&P 500 stocks to buy in April.

3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List

By Faizan Farooque, InvestorPlace Contributor Mar 29, 2024

UNH's stellar year, ABT's dividend aristocracy, MRK's AI leap: Unpacking the best strong buy healthcare stocks for 2024.

7 Dow Darlings for Investors to Buy for March Market Madness

By Alex Sirois, InvestorPlace Contributor Mar 13, 2024

These 7 Dow stocks are better positioned than the other 23 within the index making them strong buy considerations.

SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster

By Rich Duprey, InvestorPlace Contributor Mar 13, 2024

With over 100 dividend growth stocks in its portfolio, the SCHD ETF has proved to be a formidable income-generating vehicle for investors.

The Top 3 Dow Stocks to Buy in March 2024

By Charles Munyi, InvestorPlace Contributor Mar 4, 2024

Play defense with these top Dow stocks to buy as the market takes a breather from the 20% rally that started in November 2023.

7 Timeless Stocks to Invest in for 2024

By Faisal Humayun, InvestorPlace Contributor Mar 1, 2024

These are attractive timeless stocks to buy as they represent quality companies with the potential to deliver healthy total returns.

3 Long-Term Winners from Charles Schwab’s Top Picks

By Stavros Tousios, InvestorPlace Contributor Feb 27, 2024

Explore the growth and resilience of long-term stocks Microsoft, Merck and Veralto in the latest Charles Schwab stocks portfolio update.

3 Top Pharma Stocks for Investors Betting on a Biotech Boom

By Rick Orford, InvestorPlace Contributor Feb 26, 2024

Pharma stocks offer phenomenal returns when their drug gets approved. Here are three stocks that could soar in 2024.

3 Inflation-Proof Stock Picks Following Tuesday’s CPI Report

By Stavros Tousios, InvestorPlace Contributor Feb 15, 2024

Discover the strength of inflation-proof stocks through these investment picks, as they offer attractive yields and promising growth.

3 Pharma Stocks to Sell in February Before They Crash and Burn

By Ian Bezek, InvestorPlace Contributor Feb 2, 2024

The good times are coming to an end for these overpriced pharma stocks to sell this month before they crash and burn.

Why Is Evaxion Biotech (EVAX) Stock Up 30% Today?

By William White, InvestorPlace Writer Jan 24, 2024

Evaxion Biotech stock is climbing higher on Wednesday alongside news of Merck acquiring shares of EVAX for an 11.4% stake in the company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jan 24, 2024

It's time to dive into the biggest pre-market stock movers on Tuesday with a breakdown of all the latest news affecting shares this morning.

The 3 Best Dividend Growth Stocks to Buy in January 2024

By Faisal Humayun, InvestorPlace Contributor Jan 17, 2024

These are the best dividend growth stocks to buy as they represent companies with healthy free cash flow upside visibility.

Merck & Co (MRK)

Storm Shelter: 7 Safe Haven Stocks to Batten Down the Hatches

The 3 Most Undervalued Healthcare Stocks to Buy in May 2024

7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025

3 Pharma Stocks With the Potential to Make You an Overnight Millionaire

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Merck & Co (MRK)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRK Stock Predictions, Articles, and Merck & Co News

Subscriber Sign in